Abstract:Purpose: Osteoarthritis (OA) is the most prevalent form of arthritis and its impact is increasing due to the aging population and lack of effective therapies. Currently, there are no therapeutics that modify the natural history of OA, partly because of the large gaps in our understanding of the underlying molecular and cellular mechanisms of OA. Macrophage migration inhibitory factor (MIF) is a procytokine that mediates pleiotropic inflammatory effects in selected neoplasms, and inflammatory diseases (rheumatoid arthritis and ankylosing spondylitis). However, role of MIF in OA is yet to be reported. Thus, our objective was to investigate the potential role of MIF in OA in a well-established OA cohort - the Newfoundland Osteoarthritis Study (NFOAS). Methods: The study participants were derived from the NFOAS. OA patients were all end-stage knee or hip OA patients who underwent total joint replacement surgery and controls were from the same population and had NO self-reported musculoskeletal symptoms. Two previously reported functional polymorphisms in the promoter of the MIF gene (one microsatellite -794CATT5-8 and one SNP rs755662) were genotyped by TaqMan method, and the plasma concentration of the MIF protein was measured by enzyme-linked immunosorbent assay (ELISA). Further, three other frequently studied cytokines in OA including tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), and interleukin-1 beta (IL-1β) were also measured in the plasma samples by ELISA. Results: A total of 232 study participants were included in the study, 119 were OA patients and 113 OA-free controls. OA patients were significantly older (65.51 ± 8.89 years vs. 58.09 ± 6.60 years), had higher BMI (32.11 ± 6.26 kg/m2 vs. 30.02 ± 4.90 kg/m2), and more males than controls (47% females vs. 62% females) (all p<0.05). The data showed that the genotypes of the two previously reported functional polymorphisms in the MIF gene were not associated with the MIF protein levels, nor associated with OA (all p>0.05). However, we found that lower MIF protein level was significantly associated with OA (4.67±2.39 ng/ml in OA vs. 7.24±4.80 ng/ml in controls; p=4.67*10-7) (Table 1). The significance remained after adjustment for age, sex, and BMI (p=2*10-6), and the association was the same for knee and hip OA. Further, we found that an increased level of all three cytokines including TNF-α, IL-6 and IL-1β was associated with OA (Table 1), which is consistent with what reported in the literature. In the multivariable analysis with logistic regression and including all four cytokines and age, sex, and BMI, we found that lower MIF protein level and higher IL-1β were independently associated with OA (all p<3.46*10-8). TNF-α and IL-6 were not significantly associated with OA in the multivariable analysis. Conclusions: Our data showed that OA patients had a significantly lower serum MIF level. A previous study also found that a lower MIF level in synovial fluid in knee OA patients compared to healthy controls. Together, these suggest that MIF might have a protective role in OA. Further, given the evidence that a higher level of MIF is associated with RA and AS, MIF may also serve as a biomarker to differentiate OA from RA and AS.

Tissue Levels of Leukemia Inhibitory Factor Vary by Osteoarthritis Grade

Synovial Fluid Concentrations of Cold-Inducible RNA-binding Protein Are Associated with Severity in Knee Osteoarthritis

Leukemia inhibitory factor is dysregulated in ankylosing spondylitis and contributes to bone formation

The Elevated Expression of IL-38 Serves As an Anti-Inflammatory Factor in Osteoarthritis and Its Protective Effect in Osteoarthritic Chondrocytes.

The secretion of proinflammatory cytokines and chemokines in stimulated fibroblast-like synoviocytes of osteoarthritis

Association Between Wnt Inhibitory Factor-1 Expression Levels in Articular Cartilage and the Disease Severity of Patients with Osteoarthritis of the Knee

Expression of Leukaemia Inhibitory Factor in Epithelial Ovarian Carcinoma: Correlation with Clinical Characteristics

Osteoblast and Osteoclast Activity Affect Bone Remodeling Upon Regulation by Mechanical Loading-Induced Leukemia Inhibitory Factor Expression in Osteocytes

Effects Of Low-Intensity Focused Ultrasound On Cartilage And Synovium In An Experimental Model Of Osteoarthritis In Rabbits

Analysis of Interleukin 18 Levels in Patients with Osteoarthritis

Upregulation of fibroblast growth factor 1 in the synovial membranes of patients with late stage osteoarthritis

Macrophage Migration Inhibitory Factor May Play a Protective Role in Osteoarthritis

Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis

Expression of HIF-1α and VEGF in chondrocytes of articular cartilages in human advanced osteoarthritis

Influence of osteoarthritis grade on molecular signature of human cartilage

Leukemia inhibitory factor protects against experimental periodontitis through immuno‐modulations of both macrophages and periodontal ligament fibroblasts

Expression of interleukin-17 and its biological significance in serum and synovial fluid of knee oste-oarthritis

Association of Follistatin-Like 3 Concentrations in Serum and Synovial Fluid with the Radiographic Severity of Knee Osteoarthritis.

Lactoferrin Inhibits IL-1β-Induced Chondrocyte Apoptosis Through AKT1-Induced CREB1 Activation

Effects of Lentivirus-Mediated Ornithine Decarboxylase Gene on the Proliferation and Apoptosis of Fibroblast-Like Synoviocytes in Rats with Arthritis.

A Study of Serum Cartilage Oligomeric Matrixprotein and Matrix Metalloproteinase-3 Concentration in Osteoarthritic Rabbit Models